Richard Quinn is a freelance writer with The Rheumatologist.
Related Articles
APS: What Rheumatologists Should Know about Hughes Syndrome
The problem that dogs the work of all of those treating patients with antiphospholipid syndrome (APS) is the apparent lack of knowledge of the syndrome, both by the general public, as well as by swaths of the medical fraternity. Perhaps it was ever thus—a syndrome less than 40 years old could be described as new,…
Antiphospholipid Antibody Testing Update
Successes, challenges, and controversies of diagnostic methods for APS
Why Antiphospholipid Antibody Syndrome Should Be On Your Radar
With a wide range of clinical manifestations and frequent occurrence among rheumatology patients, APS is one for rheumatologists to watch
A Catalyst for Antiphospholipid Syndrome Research
APS ACTION is coordinating international efforts to study this rare and potentially fatal autoimmune disorder